Entity
Description
  • Value proposition

    Disrupting Healthcare - De-risking Innovation - Transforming Technologies

    BIOASTER Technology Research Institute (TRI) is working to develop an unique technological and innovative model to support the latest challenges in microbiology, in particular to :
    -Fight antimicrobials resistance.
    -Improve vaccines safety and efficacy.
    -Quickly diagnose infections at patient bedside.
    -take full advantage to human and animal microbiota.

    In order to overcome technological bottlenecks and explore new avenues, BIOASTER is leading collaborative projects that bring together academics, start-ups, SMEs and industrial groups around key thematic and technology units.
    Each project strives on academic research excellence and is undertaken by a team of high-level experts and engineers, which benefits from state-of-the-art equipment, technological infrastructures.

    BIOASTER, an independent non-profit organization, is one of 8 French TRIs created in 2012 on the initiative of the French Government through the “Investments for the Future” program. The two historical founders are Lyonbiopôle (a biocluster, the one-stop shop for healthcare innovation in Rhône-Alpes, France) and the Institut Pasteur in Paris. They were joined from the beginning by the CNRS, the INSERM, the CEA, Mérieux Institute, Danone Nutricia Research and Sanofi Pasteur -and newly joined by bioMérieux- to create a unique Technology Institute dedicated to infectious diseases and microbiology in health. The Institute benefits from the support of Lyon Métropole and the Region Auvergne Rhône Alpes and the dynamism of a group of 40 SMEs in the Lyon and Paris regions.

    Located in Lyon and Paris, BIOASTER has more than 100 employees including 80 world-class scientists and engineers originating from 16 different countries.

    More information on www.bioaster.org

    Biotechnology, Infectious diseases, Microbiota, Vaccines, Antimicrobials, Diagnostic, and Microbiology

  • Original language

    Disrupting Healthcare - De-risking Innovation - Transforming Technologies

    BIOASTER Technology Research Institute (TRI) is working to develop an unique technological and innovative model to support the latest challenges in microbiology, in particular to :
    -Fight antimicrobials resistance.
    -Improve vaccines safety and efficacy.
    -Quickly diagnose infections at patient bedside.
    -take full advantage to human and animal microbiota.

    In order to overcome technological bottlenecks and explore new avenues, BIOASTER is leading collaborative projects that bring together academics, start-ups, SMEs and industrial groups around key thematic and technology units.
    Each project strives on academic research excellence and is undertaken by a team of high-level experts and engineers, which benefits from state-of-the-art equipment, technological infrastructures.

    BIOASTER, an independent non-profit organization, is one of 8 French TRIs created in 2012 on the initiative of the French Government through the “Investments for the Future” program. The two historical founders are Lyonbiopôle (a biocluster, the one-stop shop for healthcare innovation in Rhône-Alpes, France) and the Institut Pasteur in Paris. They were joined from the beginning by the CNRS, the INSERM, the CEA, Mérieux Institute, Danone Nutricia Research and Sanofi Pasteur -and newly joined by bioMérieux- to create a unique Technology Institute dedicated to infectious diseases and microbiology in health. The Institute benefits from the support of Lyon Métropole and the Region Auvergne Rhône Alpes and the dynamism of a group of 40 SMEs in the Lyon and Paris regions.

    Located in Lyon and Paris, BIOASTER has more than 100 employees including 80 world-class scientists and engineers originating from 16 different countries.

    More information on www.bioaster.org

  • BIOASTER - The first Institute for technological innovation

    BIOASTER Technology Research Institute is working to develop an unique technological and innovative model to support the latest challenges in microbiology.

  • https://www.bioaster.org/
Corporate interactions BETA
Corporate TypeTweets Articles
Pouss@LYS
Pouss@LYS
Financial Services
Pouss@LYS
Financial Services
Other

19 Mar 2024


Auvergne-Rhone-Alpes Entreprises - Isère
Auvergne-Rhone-Alpes Entreprises - Isère
National and local authorities, Business Consulting and Services
Auvergne-Rhone-Alpes Entreprises - Isère
National and local authorities, Business Consulting and Services
Other

8 Dec 2023


SPIE, the international society for optics and photonics SPIE, the international society for optics and photonics
Research, Non-profit Organizations
Other

22 Jun 2023


PMT
PMT
Public business cluster, French Cluster, Civic and Social Organizations
PMT
Public business cluster, French Cluster, Civic and Social Organizations
Other

1 Jun 2023


Genopole
Genopole
Biotechnology, Biotechnology Research
Genopole
Biotechnology, Biotechnology Research
Other

22 Sep 2023


CNRS
CNRS
Research, Research Services
CNRS
Research, Research Services
Other

17 Oct 2022


Bpifrance
Bpifrance
Bank, Banking
Bpifrance
Bank, Banking
Other

8 Nov 2023


ONLYLYON
ONLYLYON
National and local authorities, Non-profit Organizations
ONLYLYON
National and local authorities, Non-profit Organizations
Other

13 Jan 2023


Medicen Paris Region
Medicen Paris Region
Public business cluster, French Cluster, Civic and Social Organizations
Medicen Paris Region
Public business cluster, French Cluster, Civic and Social Organizations
Other

22 Sep 2023


Région Auvergne-Rhône-Alpes
Région Auvergne-Rhône-Alpes
National and local authorities, Government Administration
Région Auvergne-Rhône-Alpes
National and local authorities, Government Administration
Other

8 Nov 2023


Similar entities
Loading...
Loading...
Social network dynamics